NM_014444.5:c.1065+7G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014444.5(TUBGCP4):​c.1065+7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00551 in 1,613,760 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 46 hom. )

Consequence

TUBGCP4
NM_014444.5 splice_region, intron

Scores

2
Splicing: ADA: 0.0001454
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.34

Publications

2 publications found
Variant links:
Genes affected
TUBGCP4 (HGNC:16691): (tubulin gamma complex component 4) This gene encodes a component of the gamma-tubulin ring complex, which is required for microtubule nucleation. In mammalian cells, the protein localizes to centrosomes in association with gamma-tubulin. Crystal structure analysis revealed a structure composed of five helical bundles arranged around conserved hydrophobic cores. An exposed surface area located in the C-terminal domain is essential and sufficient for direct binding to gamma-tubulin. Mutations in this gene that alter microtubule organization are associated with microcephaly and chorioretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]
TUBGCP4 Gene-Disease associations (from GenCC):
  • microcephaly and chorioretinopathy 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • microcephaly and chorioretinopathy 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 15-43395164-G-A is Benign according to our data. Variant chr15-43395164-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 437137.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00377 (574/152188) while in subpopulation NFE AF = 0.00634 (431/67990). AF 95% confidence interval is 0.00584. There are 1 homozygotes in GnomAd4. There are 285 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 46 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUBGCP4NM_014444.5 linkc.1065+7G>A splice_region_variant, intron_variant Intron 10 of 17 ENST00000564079.6 NP_055259.2 Q9UGJ1-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUBGCP4ENST00000564079.6 linkc.1065+7G>A splice_region_variant, intron_variant Intron 10 of 17 1 NM_014444.5 ENSP00000456648.2 Q9UGJ1-2
TUBGCP4ENST00000260383.11 linkc.1065+7G>A splice_region_variant, intron_variant Intron 10 of 17 1 ENSP00000260383.7 Q9UGJ1-1
TUBGCP4ENST00000561691.5 linkn.819+7G>A splice_region_variant, intron_variant Intron 8 of 16 1 ENSP00000455474.1 H3BPU4
TUBGCP4ENST00000563963.1 linkn.1084G>A non_coding_transcript_exon_variant Exon 1 of 7 2

Frequencies

GnomAD3 genomes
AF:
0.00377
AC:
574
AN:
152070
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00133
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00125
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00634
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00388
AC:
968
AN:
249520
AF XY:
0.00386
show subpopulations
Gnomad AFR exome
AF:
0.000968
Gnomad AMR exome
AF:
0.00272
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00237
Gnomad NFE exome
AF:
0.00658
Gnomad OTH exome
AF:
0.00495
GnomAD4 exome
AF:
0.00569
AC:
8311
AN:
1461572
Hom.:
46
Cov.:
30
AF XY:
0.00555
AC XY:
4033
AN XY:
727104
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33470
American (AMR)
AF:
0.00293
AC:
131
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000995
AC:
26
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39688
South Asian (SAS)
AF:
0.000777
AC:
67
AN:
86256
European-Finnish (FIN)
AF:
0.00264
AC:
141
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00692
AC:
7691
AN:
1111732
Other (OTH)
AF:
0.00379
AC:
229
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
388
776
1164
1552
1940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00377
AC:
574
AN:
152188
Hom.:
1
Cov.:
32
AF XY:
0.00383
AC XY:
285
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.00132
AC:
55
AN:
41540
American (AMR)
AF:
0.00334
AC:
51
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00125
AC:
6
AN:
4812
European-Finnish (FIN)
AF:
0.00160
AC:
17
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00634
AC:
431
AN:
67990
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00511
Hom.:
0
Bravo
AF:
0.00429
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00529
EpiControl
AF:
0.00658

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TUBGCP4: BP4, BS2 -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Sep 22, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
7.0
DANN
Benign
0.69
PhyloP100
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00015
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117773969; hg19: chr15-43687362; COSMIC: COSV105871535; COSMIC: COSV105871535; API